Oct 13, 2026
News Releases
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Read More
Media Center
Oct 01, 2026
News Releases
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Read More
Sep 08, 2026
News Releases
Generate Biomedicines Inc. to Participate in September Investor Conferences
Read More
Aug 06, 2026
News Releases
Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update
Read More
May 28, 2026
News Releases
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference
Read More
May 07, 2026
News Releases
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
Read More
Feb 26, 2026
News Releases
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
Read More
Jan 29, 2026
News Releases
Generate:Biomedicines Welcomes Aarif Khakoo, MD, MBA, as Chief Scientific Officer
Read More
Dec 01, 2025
News Releases
Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
Read More